Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Brain · 01.02.2024 · 147 (2) · 444-457
DOI: 10.1093/brain/awad388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 25.11.2023. Verfasst von Yaping Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ 85281, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Parkinsonian Disorders, Synucleinopathies. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aligning Science Across Parkinson's, Aligning Science Across Parkinson’s.
Abstract (Originalsprache)
While Parkinson’s disease remains clinically defined by cardinal motor symptoms resulting from nigrostriatal degeneration, it is now appreciated that the disease commonly consists of multiple pathologies, but it is unclear where these co-pathologies occur early in disease and whether they are responsible for the nigrostriatal degeneration. For the past number of years, we have been studying a well-characterized cohort of subjects with motor impairment that we have termed mild motor deficits. Motor deficits were determined on a modified and validated Unified Parkinson’s Disease Rating Scale III but were insufficient in degree to diagnose Parkinson’s disease. However, in our past studies, cases in this cohort had a selection bias, as both a clinical syndrome in between no motor deficits and Parkinson’s disease, plus nigral Lewy pathology as defined post-mortem, were required for inclusion. Therefore, in the current study, we only based inclusion on the presence of a clinical phenotype with mild motor impairment insufficient to diagnose Parkinson’s disease. Then, we divided this group further based upon whether or not subjects had a synucleinopathy in the nigrostriatal system. Here we demonstrate that loss of nigral dopaminergic neurons, loss of putamenal dopaminergic innervation and loss of the tyrosine hydroxylase-phenotype in the substantia nigra and putamen occur equally in mild motor deficit groups with and without nigral alpha-synuclein aggregates. Indeed, the common feature of these two groups is that both have similar degrees of AT8 positive phosphorylated tau, a pathology not seen in the nigrostriatal system of age-matched controls. These findings were confirmed with early (tau Ser208 phosphorylation) and late (tau Ser396/Ser404 phosphorylation) tau markers. This suggests that the initiation of nigrostriatal dopaminergic neurodegeneration occurs independently of alpha-synuclein aggregation and can be tau mediated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ 85281, USA.
- Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142, USA.
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
- Neurology, School of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA.
- Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Pacific Parkinson's Research Centre and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
ORCID-Profile: Yaping Chu, Ashley S Harms, A Jon Stoessl, Jeffrey H Kordower
Förderung
- Aligning Science Across Parkinson's
- Aligning Science Across Parkinson’s
Zitieren
APA
Chu, Y., Hirst, W. D., Federoff, H. J., Harms, A. S., Stoessl, A. J., & Kordower, J. H. (2024). Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease. Brain, 147(2), 444-457. https://doi.org/10.1093/brain/awad388
Vancouver
Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease. Brain. 2024;147(2):444-457. doi:10.1093/brain/awad388
BibTeX
@article{Chu2024,
author = {Chu, Yaping and Hirst, Warren D and Federoff, Howard J and Harms, Ashley S and Stoessl, A Jon and Kordower, Jeffrey H},
title = {Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease},
journal = {Brain},
year = {2024},
volume = {147},
number = {2},
pages = {444--457},
doi = {10.1093/brain/awad388}
}
EUVIMED